Clinical Trial Update: Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study examining how genetic factors influence the metabolism and clinical response to trihexyphenidyl in children…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy
• Dystonia

Drugs mentioned

• Trihexyphenidyl (trihexyphenidyl)

Snippet

Sponsor: Children's Mercy Hospital Kansas City | Conditions: Pediatric Disorder, Genetic Predisposition | Phase 1 | Status: RECRUITING